Adrian Hargrave, CEO of SEEEN, explains how the new funds will accelerate customer growth Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAssura Regulatory News (AGR)

Share Price Information for Assura (AGR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 41.14
Bid: 41.08
Ask: 41.14
Change: -0.12 (-0.29%)
Spread: 0.06 (0.146%)
Open: 41.60
High: 41.60
Low: 41.00
Prev. Close: 41.26
AGR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

2 Jul 2019 07:00

RNS Number : 1070E
Assura PLC
02 July 2019
 

2 July 2019

Assura plc

 

Trading Update

For the first quarter to 30 June 2019

 

Assura's high-quality portfolio and pipeline reinforced; GPI integration progressing well

 

Assura plc ("Assura"), the leading primary care property investor and developer, today announces its Trading Update for the first quarter to 30 June 2019.

 

Jonathan Murphy, CEO, said:

"Assura made good progress in the first quarter, further enhancing our high-quality portfolio of primary care properties. Our immediate pipeline of developments and acquisitions has never been stronger, while we disposed of 12 properties that were held for sale for cash proceeds of £17 million which was above book value.

 

"In May, we completed the purchase of primary care developer GPI and welcomed a talented new team into Assura. The acquisition boosted our immediate and extended development pipeline by an initial £92 million.

 

"We continue to source exciting opportunities to grow our portfolio and provide more of the fit-for-purpose primary care facilities that the NHS urgently needs to benefit patients and reduce pressure on the organisation.

 

"We remain confident in our outlook for the full year and in our longer-term prospects."

 

Developments and strategic acquisitions strengthen market-leading portfolio

· One development completed (Darley Dale) at a cost of £2.3 million and two moved to on site (Canterbury and St Leonards); total of 12 developments on site at the period end with a total development cost of £58 million.

· Two acquisitions completed in the period at a cost of £5.5 million.

· 12 disposals completed for £17 million cash consideration at a small premium to book value.

 

GPI acquisition expands pipeline

· Current portfolio of 554 properties.

· Immediate development pipeline of £77 million.

· Immediate acquisitions pipeline increased to £64 million, compared with £41 million at March 2019.

· Total immediate pipeline value, including on site developments, of £199 million up from £142 million at the year end.

 

Active portfolio management delivering value

· Six lease re-gears agreed on £0.3 million of rent, adding weighted average of 10 years WAULT on those properties.

· Annualised rent roll at £102.1 million post disposals.

 

Strong financial position

· As at 30 June 2019 gross debt £730 million with undrawn facilities of £230 million plus cash balance of £47.5 million.

 

 

 

ENDS

For further information, please contact:

 

Assura plc:

Jayne Cottam, CFOOrla Ball, Company SecretaryDavid Purcell, Head of Financial Reporting

 

Tel: 01925 420 660

 

Finsbury:

Gordon Simpson

James Thompson

 

Tel: 0207 251 3801

 

This announcement contains inside information as defined in Article 7 of the EU Market Abuse Regulation No 596/2014 and has been announced in accordance with the Company's obligations under Article 17 of that Regulation.

 

Notes to Editors

Assura plc, a constituent of the FTSE 250 and the EPRA* indices, is a UK REIT and long-term investor in and developer of primary care property. The company, headquartered in Warrington, works with GPs, health professionals and the NHS to create outstanding spaces for health services in our communities. At 31 March 2019, Assura's property portfolio was valued at £1,979 million.

 

Further information is available at www.assuraplc.com

 

*EPRA is a registered trademark of the European Public Real Estate Association.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTLLFLRDEILIIA
Date   Source Headline
11th Sep 20123:46 pmRNSResult of AGM
31st Aug 20123:56 pmRNSAnnual Information Update
15th Aug 20127:00 amRNSInterim Management Statement
16th Jul 20124:02 pmRNSChange of Registered Office
13th Jul 201211:16 amRNSDirector/PDMR Shareholding
2nd Jul 20124:12 pmRNSDirector/PDMR Shareholding
26th Jun 20127:00 amRNSPreliminary results for year ended 31 March 2012
30th May 20123:14 pmRNSAppointment of Joint Corporate Broker
23rd May 20122:57 pmRNSDirectorate Change
8th May 20127:00 amRNSDirectorate Change
29th Mar 20127:00 amRNSPre-close statement and Directorate Change
16th Mar 20124:38 pmRNSDirector Declaration
28th Feb 201211:10 amRNSHolding(s) in Company
27th Feb 20129:30 amRNSDirector/PDMR Shareholding
21st Feb 20129:58 amRNSDirector/PDMR Shareholding
13th Feb 20121:33 pmRNSAppointment of Auditors
9th Feb 20127:00 amRNSInterim Management Statement
30th Jan 201212:08 pmRNSDirector/PDMR Shareholding
26th Jan 20127:00 amRNSDirectorate Change
23rd Jan 20123:01 pmRNSDirector/PDMR Shareholding
4th Jan 20123:32 pmRNSDirector / PDMR Shareholding & Total Voting Rights
3rd Jan 20127:00 amRNSDirectorate Change
30th Dec 201112:10 pmRNSHolding(s) in Company
29th Dec 20114:35 pmRNSHolding(s) in Company
28th Dec 20117:00 amRNSHolding(s) in Company
28th Dec 20117:00 amRNSHolding(s) in Company
21st Dec 20113:58 pmRNSResult of Rump Placement
21st Dec 20112:18 pmRNSResult of Rights Issue
16th Dec 201112:32 pmRNSDirector/PDMR Shareholding
9th Dec 20118:16 amRNSDirector/PDMR Shareholding
6th Dec 20119:31 amRNSFurther re Rights Issue
2nd Dec 20111:50 pmRNSPublication of Prospectus
25th Nov 20111:20 pmRNSIssue of Debt
23rd Nov 20117:00 amRNSHalf Yearly Report
23rd Nov 20117:00 amRNSIssue of Equity
13th Oct 20117:00 amRNSHolding(s) in Company
8th Sep 20116:08 pmRNSAGM Statement
1st Sep 20117:00 amRNSAGM - Withdrawal of Resolution
15th Aug 20117:00 amRNSInterim Management Statement
8th Aug 201112:01 pmRNSAnnual Information Update
8th Aug 201110:38 amRNSDirectorate Change
2nd Aug 201112:53 pmRNSDirector/PDMR Shareholding
29th Jul 20114:26 pmRNSAnnual Financial Report
13th Jul 20113:05 pmRNSAdmission of ordinary shares
13th Jul 201111:13 amRNSDisposal of Pharmacy Division
21st Jun 20117:00 amRNSFinal Results
21st Jun 20117:00 amRNSSale of pharmacy division for £39.3m
15th Jun 20119:25 amRNSHolding(s) in Company
17th May 20117:00 amRNSHolding(s) in Company
13th May 20114:03 pmRNSRe Acquisition

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.